Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What excipients are combined with ruxolitinib in apotex's medication?Guselkumab patent expiration?When is tenofovir alafenamide patent expiring?What is the difference between apixaban and apixaban accord?In what ways has the generic option influenced ruxolitinib's market share?
See the DrugPatentWatch profile for Oxazepam
Oxazepam is a benzodiazepine medication and is commonly described as an intermediate-acting benzodiazepine. [1]
Standard pharmacology references describe oxazepam’s onset and relative duration in the “intermediate-acting” range, placing it alongside other intermediate benzodiazepines in clinical use. [1]
Duration helps clinicians match oxazepam to the expected treatment window (for example, to reduce anxiety symptoms without relying on a very short-acting agent, or avoiding longer-acting drugs when sleepiness or accumulation is a concern). This clinical distinction is one reason benzodiazepines are grouped by duration in authoritative drug references. [1]
When you consult drug monographs, you’ll typically find the “benzodiazepine class” and a statement of relative duration (short/intermediate/long acting), often used for counseling and clinical decision-making. Oxazepam is categorized this way in commonly cited pharmacology references. [1]
Other Questions About Oxazepam :